The CRTC1-MAML2 fusion gene identified in BMEC2 has been shown to result in activation of the Notch signaling pathway, be tumorigenic in vitro, and silencing of its fusion product reportedly inhibits tumor growth38. This evidence concerns the gene CRTC1 and neoplasm.